Global Endoscopic Vessel Harvesting Devices Market - 2023-2030

Overview

The greater saphenous vein (GSV), the conduit most frequently utilized in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. A subcutaneous tissue tunnel is made under the skin utilizing tiny incisions and an endoscopic camera that resembles a blunt dissector to execute this surgery. The exercise describes the procedure's essential steps as well as the responsibilities of the medical team performing it.

The quality of vision, instrument mobility, and general effectiveness of vessel harvesting procedures have all increased as a result of ongoing developments in endoscopic technology. Endoscopic vessel harvesting is now safer and more efficient thanks to these developments. The perceived advantages of minimally invasive surgical procedures, such as smaller incisions, less scarring, and speedier recovery, are leading more patients to ask for them. To suit patient needs, surgeons are increasingly likely to use endoscopic vascular harvesting devices.

Market Dynamics: Drivers

Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery

The greater saphenous vein (GSV), which is the most often used conduit in coronary artery bypass graft (CABG) surgery, has been harvested via endoscopic vein harvesting (EVH) over the past ten years. Due to their length and simplicity of harvesting, the saphenous veins are frequently exploited. The need for more and better conduits has grown as a result of the rising necessity for numerous coronary artery bypass surgeries among patients and the global demand for CABG operations.

The key players are offering the product to meet the demand of devices in the market. For instance, the Vasoview Hemopro 2 Endoscopic Vessel Harvesting (EVH) System features the most advanced ergonomic design available. It is the industry standard for both saphenous vein and radial artery vessel harvesting, offering great maneuverability and superb visibility to let harvesters work more productively and effectively for better patient outcomes.

In addition, it is recommended to use the Saphena Medical Venapax endoscopic vessel harvesting system during minimally invasive surgery. Primarily for patients undergoing endoscopic surgery for artery bypass, giving access to vascular harvesting. Tissue dissection along the saphenous vein for coronary artery bypass grafting and peripheral artery bypass or radial artery for coronary artery bypass grafting are examples of extremity surgeries.

The Increasing Prevalence of Cardiovascular diseases

According to World Health Organization, with 17.9 million deaths per year, cardiovascular diseases (CVDs) are the leading cause of death worldwide. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70.

In addition, the technological advances in the treatment of cardiovascular disease drive the market. For instance, as per the Journal of Visualized Surgery in 2023, Over the past few decades, coronary artery surgery has undergone significant development. Numerous of these developments have improved graft patency for patients and reduced the morbidity of cardiac surgery. Robotic completely endoscopic coronary artery bypass (TECAB) grafting is a treatment in which surgeons use a surgical robot to complete all major surgical processes, including anastomotic suturing, using endoscopic port site incisions.

Restraining Factors

The endoscopic vessel harvesting devices market, while experiencing growth, also faces various restraint factors that can hinder its development and adoption. The factors such as high cost of devices, lack of skilled surgeons, safety concerns, alternative techniques, regulatory hurdles, and limited clinical evidence.

Segment Analysis

The global endoscopic vessel harvesting devices market is segmented based on product type, application, end-user and region.

The EVH Systems segment accounted for approximately 45.8% of the market share

The greater saphenous vein (GSV), the conduit most frequently used in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. An endoscopic camera, such as a blunt dissector, must be used in conjunction with minor incisions to create a tunnel of subcutaneous tissue beneath the skin during this surgery. The activity outlines the procedure's essential steps and clarifies the roles of the healthcare team doing it.

By employing an endoscope to view the patient's body, endoscopic tools enable clinicians to carry out minimally invasive surgeries through very small incisions. When performing cardiac surgery, the VirtuoSaph Plus Endoscopic Vessel Harvesting System from Terumo is utilized to remove the patient's saphenous vein or radial artery for use as a bypass graft.

Geographical Penetration

North America segment accounted for approximately 38.6% of the market share

North America has been a dominant force in the global endoscopic vessel harvesting devices market. Infections at the sternal or conduit harvest site incisions were thought to have occurred in between 2% and 20% of coronary artery bypass grafting (CABG) surgeries performed in the United States. Although graft harvest site infections may be more frequent after CABG, deep chest infections and mediastinitis have received a lot of attention due to their potential for significant morbidity and mortality.

Gintage offers Early generation EVH users were taken into consideration during the design of the Vasoview 7xB Endoscopic Vessel Harvesting System. The 7xB platform, with its cutting-edge, responsive controls, enables you to work with confidence and enjoy quick productivity if you are most comfortable using a two-handed configuration.

As of July 2023, CardioPrecision, an expert in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, has taken another significant step by entering the US market, which is currently the largest medical device market by value in the world and represents a significant scale up for the company. This comes after its CoreVista devices were proven to be highly effective in Scotland.

CardioPrecision, a company that was spun off from the NHS through InnoScot Health, recently debuted its technology at the prestigious Massachusetts General Hospital in Boston for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) operations.

COVID-19 Impact Analysis:

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global endoscopic vessel harvesting devices market. In order to conserve resources and reduce the risk of infection for both patients and healthcare professionals during the height of the epidemic, numerous hospitals and healthcare facilities postponed or cancelled elective surgery.

As a result, there were significantly fewer procedures involving coronary artery bypass grafting (CABG), which in turn reduced the demand for endoscopic vascular harvesting equipment.

Competitive Landscape

The major global players in the market include: Getinge, Spectra Group, Terumo Corporation, KARL STORZ SE & Co. KG, Saphena Medical, Medical Instruments Spa, Sorin Group, Medical Instruments Spa, Med Europe S.r.l., and Olympus Corporation among others.

Why Purchase the Report?

• To visualize the global endoscopic vessel harvesting devices market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of endoscopic vessel harvesting devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global endoscopic vessel harvesting devices market report would provide approximately 61 tables, 56 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies